Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Language
Publication year range
1.
Copenhagen; World Health Organization. Regional Office for Europe; 2015. (WHO/EURO:2015-3225-42984-60065).
in English | WHO IRIS | ID: who-156017

ABSTRACT

This evaluation builds on a desk review and a country mission which took place on 18-21 November 2014. The preparation phase included a desk review and analysis of available documents (WHO guidelines, national policy/strategy/plans, clinical guidelines, publications, reports, etc.), as well as a review of the draft National Strategic Plan on HIV (NSP) and Concept Note (CN) to the Global Fund. The progress made during the implementation of the NSP 2011-2015 is acknowledged, in particular the increase in the number of people on ARV treatment and subsequent decrease in mortality, as well as the readiness of the government to take over funding of the HIV programme in the future. Overall the evaluation team agrees on the key priority modules as defined in the CN, which takes into account many of the recommendations presented in the evaluation from 2013.


Subject(s)
Acquired Immunodeficiency Syndrome , Republic of Belarus , Program Evaluation , HIV , National Health Programs
3.
Copenhagen; World Health Organization. Regional Office for Europe; 2014. (WHO/EURO:2014-6467-46233-66882).
in English | WHO IRIS | ID: who-146107

ABSTRACT

This WHO country mission was performed in June 2014 to assess the achievements, strengths andshortcomings in the implementation of the Georgian National HIV/AIDS Strategic Plan (NSPA)across the cascade of care, and to generate strategic recommendations for improving key outcomesand impacts. The mission had specific focus on providing recommendations on standardizingtreatment regimens, how to reduce the number of different ARV regimens, and how to optimize theHIV/AIDS investment from a public health perspective.


Subject(s)
Acquired Immunodeficiency Syndrome , Drug Costs , Drug Users , Antiretroviral Therapy, Highly Active , HIV Infections
SELECTION OF CITATIONS
SEARCH DETAIL